Wockhardt Limited has informed the Exchange regarding a press release dated August 10, 2026, titled Wockhardt Antibiotic Academy, an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance .
Wockhardt Limited Press Release Aug 10 2026
Earlier from Wockhardt
- Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis
- Press Release May 30 2026
- Press Release May 28 2026
- Press Release May 04 2026